STAT | Reporting from the frontiers of health and medicine Follow New study supports testing of Merck’s Ebola vaccine in DRC outbreak New data supports the idea that Merck’s Ebola vaccine Ervebo, licensed to target the Zaire species of ebolaviruses, could also offer some protection against another. https://www.statnews.com/2026/07/22/new-study-supports-testing-of-mercks-ebola-vaccine-in-drc-outbreak/ statnews.com
